Recombinant DNA Technology-Global Market Status and Trend Report 2013-2023

Date: May 21, 2018
Pages: 140
Price:
US$ 2,480.00
Publisher: MIReports Co., Limited
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: RC0EE02DDA78EN
Leaflet:

Download PDF Leaflet

Recombinant DNA Technology-Global Market Status and Trend Report 2013-2023
Report Summary

Recombinant DNA Technology-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Recombinant DNA Technology industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Regional Market Size of Recombinant DNA Technology 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Recombinant DNA Technology worldwide, with company and product introduction, position in the Recombinant DNA Technology market
Market status and development trend of Recombinant DNA Technology by types and applications
Cost and profit status of Recombinant DNA Technology, and marketing status
Market growth drivers and challenges

The report segments the global Recombinant DNA Technology market as:

Global Recombinant DNA Technology Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America

Global Recombinant DNA Technology Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
by Product
by Types

Global Recombinant DNA Technology Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others

Global Recombinant DNA Technology Market: Manufacturers Segment Analysis (Company and Product introduction, Recombinant DNA Technology Sales Volume, Revenue, Price and Gross Margin):
Monsanto Company
Roche
Biogen
Amgen
Novartis
Eli Lilly and Company
GenScript
Pfizer Inc.
Novo Nordisk
Sanofi
Merck KGaA
Profacgen
Biocon
GlaxoSmithKline
Cibus
Horizon Discovery Group
New England Biolabs

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF RECOMBINANT DNA TECHNOLOGY

1.1 Definition of Recombinant DNA Technology in This Report
1.2 Commercial Types of Recombinant DNA Technology
  1.2.1 by Product
  1.2.2 by Types
1.3 Downstream Application of Recombinant DNA Technology
  1.3.1 Biotechnology and Pharmaceutical Companies
  1.3.2 Academic & Government Research Institutes
  1.3.3 Others
1.4 Development History of Recombinant DNA Technology
1.5 Market Status and Trend of Recombinant DNA Technology 2013-2023
  1.5.1 Global Recombinant DNA Technology Market Status and Trend 2013-2023
  1.5.2 Regional Recombinant DNA Technology Market Status and Trend 2013-2023

CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Development of Recombinant DNA Technology 2013-2017
2.2 Sales Market of Recombinant DNA Technology by Regions
  2.2.1 Sales Volume of Recombinant DNA Technology by Regions
  2.2.2 Sales Value of Recombinant DNA Technology by Regions
2.3 Production Market of Recombinant DNA Technology by Regions
2.4 Global Market Forecast of Recombinant DNA Technology 2018-2023
  2.4.1 Global Market Forecast of Recombinant DNA Technology 2018-2023
  2.4.2 Market Forecast of Recombinant DNA Technology by Regions 2018-2023

CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES

3.1 Sales Volume of Recombinant DNA Technology by Types
3.2 Sales Value of Recombinant DNA Technology by Types
3.3 Market Forecast of Recombinant DNA Technology by Types

CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Global Sales Volume of Recombinant DNA Technology by Downstream Industry
4.2 Global Market Forecast of Recombinant DNA Technology by Downstream Industry

CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

5.1 North America Recombinant DNA Technology Market Status by Countries
  5.1.1 North America Recombinant DNA Technology Sales by Countries (2013-2017)
  5.1.2 North America Recombinant DNA Technology Revenue by Countries (2013-2017)
  5.1.3 United States Recombinant DNA Technology Market Status (2013-2017)
  5.1.4 Canada Recombinant DNA Technology Market Status (2013-2017)
  5.1.5 Mexico Recombinant DNA Technology Market Status (2013-2017)
5.2 North America Recombinant DNA Technology Market Status by Manufacturers
5.3 North America Recombinant DNA Technology Market Status by Type (2013-2017)
  5.3.1 North America Recombinant DNA Technology Sales by Type (2013-2017)
  5.3.2 North America Recombinant DNA Technology Revenue by Type (2013-2017)
5.4 North America Recombinant DNA Technology Market Status by Downstream Industry (2013-2017)

CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

6.1 Europe Recombinant DNA Technology Market Status by Countries
  6.1.1 Europe Recombinant DNA Technology Sales by Countries (2013-2017)
  6.1.2 Europe Recombinant DNA Technology Revenue by Countries (2013-2017)
  6.1.3 Germany Recombinant DNA Technology Market Status (2013-2017)
  6.1.4 UK Recombinant DNA Technology Market Status (2013-2017)
  6.1.5 France Recombinant DNA Technology Market Status (2013-2017)
  6.1.6 Italy Recombinant DNA Technology Market Status (2013-2017)
  6.1.7 Russia Recombinant DNA Technology Market Status (2013-2017)
  6.1.8 Spain Recombinant DNA Technology Market Status (2013-2017)
  6.1.9 Benelux Recombinant DNA Technology Market Status (2013-2017)
6.2 Europe Recombinant DNA Technology Market Status by Manufacturers
6.3 Europe Recombinant DNA Technology Market Status by Type (2013-2017)
  6.3.1 Europe Recombinant DNA Technology Sales by Type (2013-2017)
  6.3.2 Europe Recombinant DNA Technology Revenue by Type (2013-2017)
6.4 Europe Recombinant DNA Technology Market Status by Downstream Industry (2013-2017)

CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

7.1 Asia Pacific Recombinant DNA Technology Market Status by Countries
  7.1.1 Asia Pacific Recombinant DNA Technology Sales by Countries (2013-2017)
  7.1.2 Asia Pacific Recombinant DNA Technology Revenue by Countries (2013-2017)
  7.1.3 China Recombinant DNA Technology Market Status (2013-2017)
  7.1.4 Japan Recombinant DNA Technology Market Status (2013-2017)
  7.1.5 India Recombinant DNA Technology Market Status (2013-2017)
  7.1.6 Southeast Asia Recombinant DNA Technology Market Status (2013-2017)
  7.1.7 Australia Recombinant DNA Technology Market Status (2013-2017)
7.2 Asia Pacific Recombinant DNA Technology Market Status by Manufacturers
7.3 Asia Pacific Recombinant DNA Technology Market Status by Type (2013-2017)
  7.3.1 Asia Pacific Recombinant DNA Technology Sales by Type (2013-2017)
  7.3.2 Asia Pacific Recombinant DNA Technology Revenue by Type (2013-2017)
7.4 Asia Pacific Recombinant DNA Technology Market Status by Downstream Industry (2013-2017)

CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

8.1 Latin America Recombinant DNA Technology Market Status by Countries
  8.1.1 Latin America Recombinant DNA Technology Sales by Countries (2013-2017)
  8.1.2 Latin America Recombinant DNA Technology Revenue by Countries (2013-2017)
  8.1.3 Brazil Recombinant DNA Technology Market Status (2013-2017)
  8.1.4 Argentina Recombinant DNA Technology Market Status (2013-2017)
  8.1.5 Colombia Recombinant DNA Technology Market Status (2013-2017)
8.2 Latin America Recombinant DNA Technology Market Status by Manufacturers
8.3 Latin America Recombinant DNA Technology Market Status by Type (2013-2017)
  8.3.1 Latin America Recombinant DNA Technology Sales by Type (2013-2017)
  8.3.2 Latin America Recombinant DNA Technology Revenue by Type (2013-2017)
8.4 Latin America Recombinant DNA Technology Market Status by Downstream Industry (2013-2017)

CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY

9.1 Middle East and Africa Recombinant DNA Technology Market Status by Countries
  9.1.1 Middle East and Africa Recombinant DNA Technology Sales by Countries (2013-2017)
  9.1.2 Middle East and Africa Recombinant DNA Technology Revenue by Countries (2013-2017)
  9.1.3 Middle East Recombinant DNA Technology Market Status (2013-2017)
  9.1.4 Africa Recombinant DNA Technology Market Status (2013-2017)
9.2 Middle East and Africa Recombinant DNA Technology Market Status by Manufacturers
9.3 Middle East and Africa Recombinant DNA Technology Market Status by Type (2013-2017)
  9.3.1 Middle East and Africa Recombinant DNA Technology Sales by Type (2013-2017)
  9.3.2 Middle East and Africa Recombinant DNA Technology Revenue by Type (2013-2017)
9.4 Middle East and Africa Recombinant DNA Technology Market Status by Downstream Industry (2013-2017)

CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF RECOMBINANT DNA TECHNOLOGY

10.1 Global Economy Situation and Trend Overview
10.2 Recombinant DNA Technology Downstream Industry Situation and Trend Overview

CHAPTER 11 RECOMBINANT DNA TECHNOLOGY MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS

11.1 Production Volume of Recombinant DNA Technology by Major Manufacturers
11.2 Production Value of Recombinant DNA Technology by Major Manufacturers
11.3 Basic Information of Recombinant DNA Technology by Major Manufacturers
  11.3.1 Headquarters Location and Established Time of Recombinant DNA Technology Major Manufacturer
  11.3.2 Employees and Revenue Level of Recombinant DNA Technology Major Manufacturer
11.4 Market Competition News and Trend
  11.4.1 Merger, Consolidation or Acquisition News
  11.4.2 Investment or Disinvestment News
  11.4.3 New Product Development and Launch

CHAPTER 12 RECOMBINANT DNA TECHNOLOGY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

12.1 Monsanto Company
  12.1.1 Company profile
  12.1.2 Representative Recombinant DNA Technology Product
  12.1.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Monsanto Company
12.2 Roche
  12.2.1 Company profile
  12.2.2 Representative Recombinant DNA Technology Product
  12.2.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Roche
12.3 Biogen
  12.3.1 Company profile
  12.3.2 Representative Recombinant DNA Technology Product
  12.3.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Biogen
12.4 Amgen
  12.4.1 Company profile
  12.4.2 Representative Recombinant DNA Technology Product
  12.4.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Amgen
12.5 Novartis
  12.5.1 Company profile
  12.5.2 Representative Recombinant DNA Technology Product
  12.5.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Novartis
12.6 Eli Lilly and Company
  12.6.1 Company profile
  12.6.2 Representative Recombinant DNA Technology Product
  12.6.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Eli Lilly and Company
12.7 GenScript
  12.7.1 Company profile
  12.7.2 Representative Recombinant DNA Technology Product
  12.7.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of GenScript
12.8 Pfizer Inc.
  12.8.1 Company profile
  12.8.2 Representative Recombinant DNA Technology Product
  12.8.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Pfizer Inc.
12.9 Novo Nordisk
  12.9.1 Company profile
  12.9.2 Representative Recombinant DNA Technology Product
  12.9.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Novo Nordisk
12.10 Sanofi
  12.10.1 Company profile
  12.10.2 Representative Recombinant DNA Technology Product
  12.10.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Sanofi
12.11 Merck KGaA
  12.11.1 Company profile
  12.11.2 Representative Recombinant DNA Technology Product
  12.11.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Merck KGaA
12.12 Profacgen
  12.12.1 Company profile
  12.12.2 Representative Recombinant DNA Technology Product
  12.12.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Profacgen
12.13 Biocon
  12.13.1 Company profile
  12.13.2 Representative Recombinant DNA Technology Product
  12.13.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Biocon
12.14 GlaxoSmithKline
  12.14.1 Company profile
  12.14.2 Representative Recombinant DNA Technology Product
  12.14.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of GlaxoSmithKline
12.15 Cibus
  12.15.1 Company profile
  12.15.2 Representative Recombinant DNA Technology Product
  12.15.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Cibus
12.16 Horizon Discovery Group
12.17 New England Biolabs

CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF RECOMBINANT DNA TECHNOLOGY

13.1 Industry Chain of Recombinant DNA Technology
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis

CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF RECOMBINANT DNA TECHNOLOGY

14.1 Cost Structure Analysis of Recombinant DNA Technology
14.2 Raw Materials Cost Analysis of Recombinant DNA Technology
14.3 Labor Cost Analysis of Recombinant DNA Technology
14.4 Manufacturing Expenses Analysis of Recombinant DNA Technology

CHAPTER 15 REPORT CONCLUSION

CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Reference
Skip to top


Ask Your Question

Recombinant DNA Technology-Global Market Status and Trend Report 2013-2023
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: